London, Greater London, United Kingdom
Chief Executive Officer at Autifony Therapeutics Limited
Pharmaceuticals
Education
Bristol University 1990 — 1994
PhD, Dopamine receptors and schizophrenia
Bristol University 1986 — 1989
BSc.Hons, Pharmacology
Repton School 1981 — 1985
Experience
Autifony Therapeutics Limited June 2014 - Present
Autifony Therapeutics Limited August 2011 - Present
Aptuit July 2010 - August 2011
GlaxoSmithKline January 2001 - June 2010
GlaxoWellcome October 1995 - December 2000
Glaxo Group Research October 1989 - October 1995
Skills
Ion Channels, Translational Medicine, R&D, Drug Development, Psychiatry, Scientific..., Cell Biology, Biotechnology, Transcranial Magnetic..., Clinical Development, Drug Metabolism, Biomarkers, HPLC, Pharmacokinetics, Neurodegeneration, Electrophysiology, ADME, CRO, Target Identification, Neuroscience, Assay Development, Cell Culture, Clinical Research, In Vivo, Biochemistry, Western Blotting, Pharmacology, Drug Design, In Vitro, Technology Transfer, GPCRs, GLP, Pharmacodynamics, Molecular Pharmacology, Cell, Lead Change, Clinical Pharmacology, Lifesciences, Life Sciences, Immunohistochemistry, Translational Research, Pharmaceutical Research, Clinical Trials, Neuropharmacology, Animal Models, Drug Discovery, Regulatory Affairs, Pharmaceutical Industry, Biomarker Discovery, Medicinal Chemistry